drugset / Trial / NCT03747978

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

NCT03747978

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This was a double-blinded randomized controlled trial of 24-hour blood pressure control in sub Saharan type 2 diabetes patients, newly diagnosed for hypertension. They were allocated to receive either a fixed combination of perindopril + amlodipine or perindopril + indapamide for 42 days.

Timeline

Start
2016-10-01
Primary completion
2017-05-30
Completion
2017-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Comparator Indapamide Small molecule 1.25 mg
Comparator Perindopril Small molecule 5 mg